-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZAMEND NEURO INC: PLANS TO INITIATE PHASE II CLINICAL STUDY OF AL001 FOR TREATMENT OF PATIENTS WITH PTSD IN Q4 2025

Reuters·03/11/2025 12:14:38

Please log in to view news